SCHEMBL26256409

SCHEMBL26256409

CCNC(=O)c1cc(-c2cccnc2)on1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.65
KMT2A Q03164 4/20 0.65
SMN1; SMN2 Q16637 3/20 0.65
TP53 P04637 7/20 0.61
NPC1 O15118 6/20 0.61
POLB P06746 2/20 0.61
LMNA P02545 1/20 0.61
KDM4E B2RXH2 2/20 0.57
MEN1 O00255 2/20 0.57
HSD17B10 Q99714 1/20 0.57
PKM P14618 3/20 0.55
CYP1A2 P05177 1/20 0.55
CYP3A4 P08684 1/20 0.55
HPGD P15428 1/20 0.55
CYP2C19 P33261 1/20 0.55
MAPT P10636 3/20 0.54
ALDH1A1 P00352 2/20 0.53
HTT P42858 2/20 0.53
MAPK1 P28482 1/20 0.52
TSHR P16473 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3413851 0.85 RAB9A (0.62) RAB9AKMT2ASMN1; SMN2TP53NPC1
SCHEMBL17788443 0.85 HIF1A (0.68) RAB9AKMT2ASMN1; SMN2TP53NPC1
SCHEMBL2115530 0.84 RAB9A (0.61) RAB9AKMT2ASMN1; SMN2TP53NPC1
SCHEMBL17788518 0.80 SCD (0.55) RAB9AKMT2ASMN1; SMN2TP53NPC1
SCHEMBL13363887 0.80 TP53 (0.59) RAB9AKMT2ASMN1; SMN2TP53NPC1
SCHEMBL7424477 0.79 L3MBTL1 (0.52) RAB9AKMT2ASMN1; SMN2TP53NPC1
SCHEMBL30046162 0.79 L3MBTL1 (0.52) RAB9AKMT2ASMN1; SMN2TP53NPC1
SCHEMBL31039788 0.79 ALDH1A1 (0.70) RAB9AKMT2ASMN1; SMN2TP53NPC1
SCHEMBL369290 0.79 ALDH1A1 (0.70) RAB9AKMT2ASMN1; SMN2TP53NPC1
SCHEMBL946826 0.78 MKNK1 (0.50) HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3856735-B1 FUSED BICYCLIC HETEROCYCLES AS THERAPEUTIC AGENTS UNIV NEW YORK (US) 2023-09-06 EP disclosed